Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

Essential oils and COVID-19: Industry warns no

sufficient evidence for efficacy amid sales surge


By Guan Yu Lim
06-Apr-2020 - Last updated on 06-Apr-2020 at 00:57 GMT

RELATED TAGS: Essential oils, Japan, COVID-19

The ongoing coronavirus (COVID-19) outbreak has


seen a surge in demand for essential oils with
claims of antiviral and antibacterial effects,
although the industry has warned there are no
sufficient evidence of its efficacy against the
pandemic.

Japanese OEM manufacturer of aromas and fragrances, Alfa-Point, said demand for its tea tree
and eucalyptus-based essential oils were growing.

Ryuichi Sugawara, president of Alfa-Point, told CosmeticsDesign-Asia that sales of its essential oils
grew more than 35% year-on-year.

“Since the situation of coronavirus has not yet returned to normal, there is a possibility that it (sales)
will grow further in the future.”

Its tea tree and eucalyptus-based essential oil contain tea tree (from Australia), eucalyptus (from
China), as well as purified water and ethanol.

He said: “Other than those listed in the Japanese Pharmacopoeia, essential oils that do not fall under
the category of cosmetics and do not declare any medicinal properties are miscellaneous goods by
law despite having high concentrations of aromatic components and therapeutic components.”

According to him, there are currently no regulations for sales and import of essential oils.

The company is currently working on conducting an “antiviral test” of its essential oil at the
Kanagawa Institute of Industrial Science and Technology.

Scientific evidence

Essential oils have been previously studied for its effect on the influenza virus both in vitro and in
vivo.
Daryl Thompson, director of scientific initiatives at Singapore biomedical firm Global Biolife told
CosmeticsDesign-Asia, "There is existing research that verify that compounds contained within
essential oils do indeed have antimicrobial properties including that of viruses as well as specific
strains of coronaviruses."

However, he stressed that studies had not been undertaken on COVID-19.

Market survey and advice

According to a survey by the Japan Aroma Environment Association (AEAJ) on the aroma market,
the market was valued at JPY 356.4 billion (USD3.3 billion) in 2018, which was up 7% from 2015.

By segment, essential oil formulated products accounted for the bulk, at JPY 301.2 billion (USD
2.8 billion).

As aromas are increasingly incorporated into consumers lifestyles, the AEAJ warns consumers
that there is plenty of disinformation on websites about using essential oils to combat the
coronavirus. 

AEAJ expressed that, “(There is still) no evidence to show that the antiviral effects of essential oils are
effective against COVID-19. It is crucial to be throughout on handwashing and keeping adequate social
distance to stay safe."

Even for Global Biolife which is currently developing a fragrance formulation to fight another
infectious disease, tuberculosis, Thompson told us, "During the present global emergency, I would
recommend that manufactures strictly adhere to good manufacturing processes and not take
advantage of the situation to sell untested products,

“While scientifically we can agree that some essential oils have virucidal properties, the best defense
for this current outbreak is to wash your hands diligently."

Warning notice

In March, the US Food and Drug Administration (FDA) issued several warning letters to
companies which market their products as a prevention or treatment for COVID-19.

Among these companies is a UK-based essential oil business, Quinessence Aromatherapy LTD,
and US-based GuruNanda LLC.

The FDA stated: “The FDA has determined that your website offers essential oil products for sale in
the United States and that these products are intended to mitigate, prevent, treat, cure or diagnose
COVID-19 in people. FDA has determined that these products are unapproved new drugs sold in
violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a).”

Copyright - Unless otherwise stated all contents of this web site are © 2020 - William Reed Business Media Ltd -
All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
RELATED TOPICS: All Asia-Pacific, Market Trends, Regulation & Safety, COVID-19, Fragrance

You might also like